Advertisement

Intensive Care Medicine

, Volume 34, Issue 6, pp 1163–1164 | Cite as

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  • Julian BionEmail author
  • Roman Jaeschke
  • B. Taylor Thompson
  • Mitchell Levy
  • R. Phillip Dellinger
Correspondence

Sir: The process of converting scientific evidence into clinical guidelines involves making judgments. Few judgments are absolute – there is usually a penumbra of uncertainty around the decision, and the decision itself will be influenced by factors which may not be answered by current evidence. We used a voting process to identify the point of consensus and the extent of uncertainty for those elements of the guidelines for which there was no unanimity. These included selective digestive tract decontamination (SDD), steroids, glucose control, and activated protein C, among others.

Drs. Spoelstra and Girbes correctly draw attention to the divergence between the scientific literature in favor of SDD and the absence of a recommendation by the guidelines group. However, they describe this as bias, and we would not use this term. The voting process demonstrated the presence either of maximal uncertainty (from a group perspective), or of polarized views, one weakly opposed and the other...

Keywords

Cimetidine Ranitidine Survive Sepsis Campaign Stress Ulcer Prophylaxis Vote Process 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Thompson BT, Clemmer TP, Ahrens T, Levy MM, Vincent JL, Dellinger RP (2008) The new Surviving Sepsis Campaign recommendations on glucose control: reply to Schultz et al. Intensive Care Med DOI  10.1007/s00134-008-1028-5
  2. 2.
    Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461PubMedCrossRefGoogle Scholar
  3. 3.
    Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRefGoogle Scholar
  4. 4.
    Preiser JC (2007) Intensive glycemic control in med-surg patients (European Glucontrol trial). In: Program and abstracts of the Society of Critical Care Medicine 36th Critical Care Congress, Orlando, Florida, 17–21 Feb 2007Google Scholar
  5. 5.
    Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A (2000) Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321:1–7CrossRefGoogle Scholar
  6. 6.
    Cook DJ, Witt LG, Cook RJ, Guyatt GH (1991) Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 91:519–527PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Julian Bion
    • 1
    Email author
  • Roman Jaeschke
    • 2
  • B. Taylor Thompson
    • 3
  • Mitchell Levy
    • 4
  • R. Phillip Dellinger
    • 5
  1. 1.Department of Intensive Care MedicineUniversity of BirminghamBirminghamUK
  2. 2.Department of MedicineMcMaster UniversityHamiltonCanada
  3. 3.Pulmonary and Critical Care Unit, Department of MedicineMassachusetts General HospitalBostonUSA
  4. 4.Rhode Island Hospital, Brown University School of MedicineProvidenceUSA
  5. 5.Division of Critical Care MedicineCooper University Hospital, Robert Wood Johnson Medical SchoolCamdenUSA

Personalised recommendations